Argentinean epidemiological study reveals the staggering costs of osteoporosis in the country

16 July 2010

The key findings of the first Argentinean study on epidemiology, costs and burden of osteoporosis have revealed the staggering costs of the disease to the country. These findings include:

' In Argentina, bone mineral density studies reveal that one out of three women aged 50 or over suffers from osteoporosis.

' The prevalence of vertebral fractures in Argentinean women aged 50 or older is 16%.
' Over 34,000 hip fractures occur every year among the 50 years or older population, with an average of 90 fractures per day.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight